[HTML][HTML] Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective
S Finocchario-Kessler, C Wexler, M Maloba… - BMC women's …, 2016 - Springer
Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …
cancer. Research and investment to improve vaccination, screening, and treatment efforts …
Educational interventions to increase HPV vaccination acceptance: a systematic review
Abstract Background The Human papillomavirus (HPV) vaccine has been available for
protection against HPV-associated cervical cancer and genital warts since 2006 …
protection against HPV-associated cervical cancer and genital warts since 2006 …
Valuing vaccination
T Bärnighausen, DE Bloom… - Proceedings of the …, 2014 - National Acad Sciences
Vaccination has led to remarkable health gains over the last century. However, large
coverage gaps remain, which will require significant financial resources and political will to …
coverage gaps remain, which will require significant financial resources and political will to …
[HTML][HTML] Reduction of low-and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
KGJ Pollock, K Kavanagh, A Potts, J Love… - British journal of …, 2014 - nature.com
Background: In Scotland, a national HPV immunisation programme began in 2008 for 12-to
13-year olds, with a catch-up campaign from 2008 to 2011 for those under the age of 18. To …
13-year olds, with a catch-up campaign from 2008 to 2011 for those under the age of 18. To …
Next generation prophylactic human papillomavirus vaccines
JT Schiller, M Müller - The lancet oncology, 2015 - thelancet.com
The two licensed bivalent and quadrivalent human papillomavirus (HPV) L1 (the major
papillomavirus virion protein) virus-like particle (VLP) vaccines are regarded as safe …
papillomavirus virion protein) virus-like particle (VLP) vaccines are regarded as safe …
[PDF][PDF] American society of clinical oncology statement: human papillomavirus vaccination for cancer prevention
HH Bailey, LT Chuang, NC DuPont… - Journal of Clinical …, 2016 - izsummitpartners.org
ABSTRACT American Society of Clinical Oncology (ASCO), the leading medical
professional oncology society, is committed to lessening the burden of cancer and as such …
professional oncology society, is committed to lessening the burden of cancer and as such …
[HTML][HTML] Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine …
W Mendes Lobão, FG Duarte, JD Burns… - PloS one, 2018 - journals.plos.org
Background The World Health Organization has recommended the introduction of HPV
vaccines into national immunization programme (NIP), but vaccination coverage remains …
vaccines into national immunization programme (NIP), but vaccination coverage remains …
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon
A Chatterjee - Expert review of vaccines, 2014 - Taylor & Francis
HPV infection with 'high-risk'genotypes is associated with ano-genital and oropharyngeal
cancers. Two currently licensed prophylactic HPV vaccines designed to prevent disease …
cancers. Two currently licensed prophylactic HPV vaccines designed to prevent disease …
General practitioners' attitudes and behaviors toward HPV vaccination: A French national survey
F Collange, L Fressard, C Pulcini, R Sebbah… - Vaccine, 2016 - Elsevier
Abstract Objective General practitioners (GPs) play a crucial role in human papillomavirus
(HPV) vaccine acceptance in France. We sought to study:(1) GPs' perceptions of its risks and …
(HPV) vaccine acceptance in France. We sought to study:(1) GPs' perceptions of its risks and …
[HTML][HTML] Attitudes toward HPV vaccination in Sweden: A survey study
M Wemrell, L Gunnarsson - Frontiers in Public Health, 2022 - frontiersin.org
Background While HPV vaccination uptake in Sweden is quite high, at around 80%, vaccine
hesitancy remains an issue in countries throughout Europe. The latter can be related to a …
hesitancy remains an issue in countries throughout Europe. The latter can be related to a …